Allergan reprimanded over Botox promotion
March 19, 2014Medical Communications, Sales and Marketing ABPI, Allergan, Botox, Galderma, PMCPA, vistabel
Allergan has been found guilty of breaching six clauses of the ABPI’s Code of Practice over its market research for …
Merck Serono appoints head of strategy from Roche
March 19, 2014Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Meeta Gulyani, Merck Serono, Roche
Merck Serono the German biopharma division of Merck has appointed Meeta Gulyani to the position of head of strategy and …
Europe: TB treatment ‘far below’ target
March 19, 2014Research and Development, Sales and Marketing EU, MDR TB, TB, WHO, tuberculosis
European countries are still not getting to grips with the diagnosis and treatment of tuberculosis, according to a new report …
Success for Amgen’s ‘bad’ cholesterol injection
March 18, 2014Research and Development, Sales and Marketing Amgen, LDL, PCSK9, evolocumab, hofh, tesla
An investigational PCSK9 Inhibitor from Amgen has reduced LDL-C (‘bad’ cholesterol) in patients suffering from a rare genetic disorder in …
BMS hopes for Yervoy sequel with new deal
March 18, 2014Research and Development, Sales and Marketing Avapro, BMS, Plavix, Yervoy, five prime, immune-oncology
Bristol-Myers Squibb has announced a new research and development deal with Five Prime Therapeutics aimed at discovering potentially new cancer …
Pfizer sues over Viagra generic
March 18, 2014Sales and Marketing ED, FDA, Pfizer, Sildenafil, torrent, viagra
Pfizer is suing Torrent Pharmaceuticals in order to stop it selling copycat versions on its big-selling erectile-dysfunction drug Viagra. The …
Patheon completes $2.65 billion merger with DSM
March 18, 2014Manufacturing and Production, Sales and Marketing CDMO, DSM, Patheon, dpx, manufacturing
The $2.65 billion merger between Patheon and DSM’s pharma business has completed, creating a new privately-held company called DPx. The …
IDEA Pharma appoints vice president
March 18, 2014Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing IDEA Pharma, Jacquelyn Nicholson
Biopharma firm IDEA Pharma has appointed Jacquelyn Nicholson as vice president to head up its west coast US operations. Nicholson …
Pharma manufacturing news in brief
March 18, 2014Manufacturing and Production Aesica, Alvotech, Codexis/Intrexon, Pluristem, Updates from Bayer
Bayer says it plans to invest more than €500 million to establish additional manufacturing capacity for its haemophilia drugs at …
Sun Pharma comes under FDA import alert
March 17, 2014Manufacturing and Production Sun Pharma, diabetes, gabapentin, manufacturing, metformin, recall
The reputation of India’s pharma sector has been dealt a further blow after yet another drugmaker was placed under an …
Novo Nordisk unveils plans for $100m API plant
March 17, 2014Manufacturing and Production API, FDA, Novo Nordisk, Taylor, copenhagen
Novo Nordisk says it will invest around $100m in a new pilot facility to make the active pharmaceutical ingredients (APIs) …
Boehringer’s first cancer drug gains NICE yes
March 17, 2014Sales and Marketing Boehringer, Cancer, NICE, NSCLC, afatinib, giotrif
NICE is recommending that Boehringer Ingelheim’s first oncology treatment Giotrif be funded by the NHS. The new final draft guidance …
Amgen melanoma vaccine shrinks tumours
March 17, 2014Research and Development, Sales and Marketing Amgen, Cancer, Yervoy, melanoma, t-vec
Amgen’s investigational cancer vaccine T-vec has managed to shrink the size of advanced melanoma tumours in a late-stage trial. The …
Major new launches for 2014
March 17, 2014Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing AZ, AbbVie, Big Pharma, Merck, Novartis, Pfizer, Roche, Sanofi, ask, johnson, lilly, top 10
AbbVie AbbVie needs a blockbuster to eventually replace its flagship Humira – and is hoping its new hepatitis C treatments …
IMS Health appoints general manager
March 17, 2014Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing IMS Health, sheppard
Technology services firm IMS Health has named Tim Sheppard as the new general manager for its UK and Ireland business. Sheppard …
EFPIA targets MEPs in social media campaign
March 17, 2014Medical Communications, Sales and Marketing EFPIA, EU, bergstrom, pharma summit, social media
The European Federation of Pharmaceutical Industries and Associations (EFPIA) has launched a social media campaign aimed at MEPs. With ten …
NHS unions threaten action
March 14, 2014Sales and Marketing Hunt, NHS, UK, nhsprb, nurses
Unions representing NHS staff in England have reacted strongly to a new round of below-inflation pay rises and have threatened …
New director named at Celgene
March 14, 2014Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Celgene, moore
Biopharma firm Celgene has appointed Rob Moore as its new Inflammation and Immunology business unit director. Moore has worked in …
BIA ‘disappointed’ by early access funding
March 14, 2014Research and Development, Sales and Marketing BIA, NHS, bates, dams, early access
The BioIndustry Association (BIA) is ‘disappointed’ that the government is not funding the much-anticipated Early Access to Medicines Scheme (EAMS). …
Pharma must use cloud-based tech, says report
March 13, 2014Medical Communications, Sales and Marketing IMS, cloud, digital, pharma, technology
Cloud-based technologies are the way forward for the pharma sector as global budget pressures continue to bite – that is …
Latest content
Pharma sees climate disruption as growing supply-chain risk
Manchester NHS-MHRA partnership to test new technologies in real-world care
